These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 11448951
1. Identification of tumor necrosis factor (TNF) amino acids crucial for binding to the murine p75 TNF receptor and construction of receptor-selective mutants. Ameloot P, Fiers W, De Bleser P, Ware CF, Vandenabeele P, Brouckaert P. J Biol Chem; 2001 Oct 05; 276(40):37426-30. PubMed ID: 11448951 [Abstract] [Full Text] [Related]
2. Bioavailability of recombinant tumor necrosis factor determines its lethality in mice. Ameloot P, Takahashi N, Everaerdt B, Hostens J, Eugster HP, Fiers W, Brouckaert P. Eur J Immunol; 2002 Oct 05; 32(10):2759-65. PubMed ID: 12355427 [Abstract] [Full Text] [Related]
3. Heterotrimers formed by tumor necrosis factors of different species or muteins. Ameloot P, Declercq W, Fiers W, Vandenabeele P, Brouckaert P. J Biol Chem; 2001 Jul 20; 276(29):27098-103. PubMed ID: 11371574 [Abstract] [Full Text] [Related]
4. Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF. Vercammen D, Vandenabeele P, Declercq W, Van de Craen M, Grooten J, Fiers W. Cytokine; 1995 Jul 20; 7(5):463-70. PubMed ID: 7578985 [Abstract] [Full Text] [Related]
5. Role of tumor necrosis factor species in the sequence-dependent effects of interleukin-2--tumor necrosis factor immunotherapy in mice: implications for preclinical cytokine testing. Owen-Schaub LB, Santee SM, Winkelhake JL, Zimmerman RJ. J Immunother Emphasis Tumor Immunol; 1994 Jan 20; 15(1):1-10. PubMed ID: 8110725 [Abstract] [Full Text] [Related]
6. Species specificity of human and murine tumor necrosis factor. A comparative study of tumor necrosis factor receptors. Smith RA, Kirstein M, Fiers W, Baglioni C. J Biol Chem; 1986 Nov 15; 261(32):14871-4. PubMed ID: 3021754 [Abstract] [Full Text] [Related]
7. Human tumor necrosis factor mutants with preferential binding to and activity on either the R55 or R75 receptor. Van Ostade X, Vandenabeele P, Tavernier J, Fiers W. Eur J Biochem; 1994 Mar 15; 220(3):771-9. PubMed ID: 8143731 [Abstract] [Full Text] [Related]
8. Exploring interaction of TNF and orthopoxviral CrmB protein by surface plasmon resonance and free energy calculation. Ivanisenko NV, Tregubchak TV, Saik OV, Ivanisenko VA, Shchelkunov SN. Protein Pept Lett; 2014 Mar 15; 21(12):1273-81. PubMed ID: 25101631 [Abstract] [Full Text] [Related]
9. An apoptosis-inducing gene therapy for pancreatic cancer with a combination of 55-kDa tumor necrosis factor (TNF) receptor gene transfection and mutein TNF administration. Sato T, Yamauchi N, Sasaki H, Takahashi M, Okamoto T, Sakamaki S, Watanabe N, Niitsu Y. Cancer Res; 1998 Apr 15; 58(8):1677-83. PubMed ID: 9563482 [Abstract] [Full Text] [Related]
10. Autocrine inhibition of leptin production by tumor necrosis factor-alpha (TNF-alpha) through TNF-alpha type-I receptor in vitro. Yamaguchi M, Murakami T, Tomimatsu T, Nishio Y, Mitsuda N, Kanzaki T, Kurachi H, Shima K, Aono T, Murata Y. Biochem Biophys Res Commun; 1998 Mar 06; 244(1):30-4. PubMed ID: 9514868 [Abstract] [Full Text] [Related]
11. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GH, Chen EY, Goeddel DV. Proc Natl Acad Sci U S A; 1991 Apr 01; 88(7):2830-4. PubMed ID: 1849278 [Abstract] [Full Text] [Related]
12. Role of LPS and receptor subtypes in the uptake of TNF by the murine lung. Ortiz LA, Friedman M, Banks WA. Life Sci; 2001 Jul 06; 69(7):791-802. PubMed ID: 11487091 [Abstract] [Full Text] [Related]
13. Tumor necrosis factor p55 receptor (TNF-RI) mediates the in vitro inhibition of hepatic erythropoietin production. Jelkmann W, Hellwig-Buergel T. Exp Hematol; 1999 Feb 06; 27(2):224-8. PubMed ID: 10029160 [Abstract] [Full Text] [Related]
14. Biological activities of human tumor necrosis factor-alpha and its novel mutants. Xi T, Shi X, Guo D, Dong X, Xu X, Zhu D. Biochem Mol Biol Int; 1996 May 06; 38(6):1183-9. PubMed ID: 8739040 [Abstract] [Full Text] [Related]
15. Increased expression of functionally active membrane-associated tumor necrosis factor in acute respiratory distress syndrome. Armstrong L, Thickett DR, Christie SJ, Kendall H, Millar AB. Am J Respir Cell Mol Biol; 2000 Jan 06; 22(1):68-74. PubMed ID: 10615067 [Abstract] [Full Text] [Related]
16. Mutation of proline 211 reduces shedding of the human p75 TNF receptor. Herman C, Chernajovsky Y. J Immunol; 1998 Mar 01; 160(5):2478-87. PubMed ID: 9498793 [Abstract] [Full Text] [Related]
17. Studies on interaction between hTNF-alpha and its two receptors with expressed hsTR55-preS1/hsTR75-preS1 fusion soluble receptors. Fang J, Lu F, Wang DB, Chen CQ. J Immunol Methods; 2003 Mar 01; 274(1-2):199-207. PubMed ID: 12609545 [Abstract] [Full Text] [Related]
18. Biological activities of human tumor necrosis factor-alpha and its novel mutants. Xi T, Shi X, Guo D, Dong X, Xu X, Zhu D. Biochem Mol Biol Int; 1996 Apr 01; 38(4):855-62. PubMed ID: 8728116 [Abstract] [Full Text] [Related]
19. Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2. Reinhard C, Shamoon B, Shyamala V, Williams LT. EMBO J; 1997 Mar 03; 16(5):1080-92. PubMed ID: 9118946 [Abstract] [Full Text] [Related]
20. Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia. Catalano MG, Fortunati N, Arena K, Costelli P, Aragno M, Danni O, Boccuzzi G. Int J Oncol; 2003 Aug 03; 23(2):429-36. PubMed ID: 12851692 [Abstract] [Full Text] [Related] Page: [Next] [New Search]